190 related articles for article (PubMed ID: 22381763)
1. [Comparison of two mouse models of lung fibrosis induced by intratracheal instillation and intratracheal aerosol administration of bleomycin].
Li W; Hu Y; Yuan W; Li L; Huang W
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Feb; 32(2):221-5. PubMed ID: 22381763
[TBL] [Abstract][Full Text] [Related]
2. [Murine pulmonary fibrosis model induced by repeated low-dose intravenous injection and intratracheal instillation of bleomycin].
Meng J; Peng Z; Tao L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Dec; 38(12):1228-32. PubMed ID: 24384960
[TBL] [Abstract][Full Text] [Related]
3. Intratracheal administration of activated protein C inhibits bleomycin-induced lung fibrosis in the mouse.
Yasui H; Gabazza EC; Tamaki S; Kobayashi T; Hataji O; Yuda H; Shimizu S; Suzuki K; Adachi Y; Taguchi O
Am J Respir Crit Care Med; 2001 Jun; 163(7):1660-8. PubMed ID: 11401891
[TBL] [Abstract][Full Text] [Related]
4. [Losartan in the rat model of bleomycin-induced pulmonary fibrosis and its impact on the expression of monocyte chemoattractant protein-1 and basic fibroblast growth factor].
Fang X; Zhu Y; Hu X; Liu Y
Zhonghua Jie He He Hu Xi Za Zhi; 2002 May; 25(5):268-72. PubMed ID: 12133317
[TBL] [Abstract][Full Text] [Related]
5. [Experimentally induced bleomycin pulmonary toxicity--comparison of the systemic (intraperitoneal) and local (intratracheal) administration].
Ekimoto H; Takahashi K; Matsuda A; Umezawa H
Gan To Kagaku Ryoho; 1983 Dec; 10(12):2550-7. PubMed ID: 6197032
[TBL] [Abstract][Full Text] [Related]
6. Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice.
Shimbori C; Shiota N; Okunishi H
Eur J Pharmacol; 2011 Jan; 650(1):424-30. PubMed ID: 21034736
[TBL] [Abstract][Full Text] [Related]
7. A comparative study of intratracheal and aerosolization instillations of bleomycin inducing experimental lung fibrosis in rat.
Abidi A; Bahri S; Ben Khamsa S; Legrand A
Toxicol Mech Methods; 2019 Feb; 29(2):75-85. PubMed ID: 30106319
[TBL] [Abstract][Full Text] [Related]
8. [The pivotal role of CXCR3 in the pathogenesis of bleomycin-induced pulmonary fibrosis].
Gao JM; Lu B
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Jan; 28(1):28-32. PubMed ID: 15774188
[TBL] [Abstract][Full Text] [Related]
9. Losartan attenuates bleomycin-induced pulmonary fibrosis in rats.
Yao HW; Zhu JP; Zhao MH; Lu Y
Respiration; 2006; 73(2):236-42. PubMed ID: 16330873
[TBL] [Abstract][Full Text] [Related]
10. [Baicalin prevents the up-regulation of connective tissue growth factor in fibrotic lungs of rats].
Jia H; Chen XL; Chen C; Hu YY; Yun XJ
Sheng Li Xue Bao; 2010 Dec; 62(6):535-40. PubMed ID: 21170500
[TBL] [Abstract][Full Text] [Related]
11. Effect of pravastatin on bleomycin-induced acute lung injury and pulmonary fibrosis.
Kim JW; Rhee CK; Kim TJ; Kim YH; Lee SH; Yoon HK; Kim SC; Lee SY; Kwon SS; Kim KH; Kim YK
Clin Exp Pharmacol Physiol; 2010 Nov; 37(11):1055-63. PubMed ID: 20659133
[TBL] [Abstract][Full Text] [Related]
12. Local delivery of biodegradable pirfenidone nanoparticles ameliorates bleomycin-induced pulmonary fibrosis in mice.
Trivedi R; Redente EF; Thakur A; Riches DW; Kompella UB
Nanotechnology; 2012 Dec; 23(50):505101. PubMed ID: 23186914
[TBL] [Abstract][Full Text] [Related]
13. [Effects of valsartan on bleomycin-induced pulmonary fibrosis in rats and the expression of hepatocyte growth factor in lung tissue].
Liu F; Xu QY; Ye YQ
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Jul; 28(7):479-83. PubMed ID: 16115399
[TBL] [Abstract][Full Text] [Related]
14. Combining histology and biochemical measurements of connective tissue components in small samples of lung: application to bleomycin-induced fibrosis in the mouse.
Starcher B; Kuhn C
Exp Lung Res; 2003; 29(3):179-94. PubMed ID: 12637229
[TBL] [Abstract][Full Text] [Related]
15. [Inhalation of glucocorticosteroid in the rat model of bleomycin-induced pulmonary fibrosis and its impact on the expression of basic fibroblast growth factor].
Mu JQ; Li GQ; Wei LQ
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2010 Aug; 26(3):330-3. PubMed ID: 21038683
[TBL] [Abstract][Full Text] [Related]
16. [The effect of curcumin on bleomycin-induced pulmonary fibrosis in rats].
Zhang DP; Qiu H; Zhuang Y; Meng FQ
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):197-201. PubMed ID: 17572999
[TBL] [Abstract][Full Text] [Related]
17. Suppression of plasminogen activator inhibitor-1 by RNA interference attenuates pulmonary fibrosis.
Senoo T; Hattori N; Tanimoto T; Furonaka M; Ishikawa N; Fujitaka K; Haruta Y; Murai H; Yokoyama A; Kohno N
Thorax; 2010 Apr; 65(4):334-40. PubMed ID: 20388759
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of bleomycin-induced pulmonary fibrosis in mice by the matrix metalloproteinase inhibitor batimastat.
Corbel M; Caulet-Maugendre S; Germain N; Molet S; Lagente V; Boichot E
J Pathol; 2001 Apr; 193(4):538-45. PubMed ID: 11276015
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of elastin and alpha 1(I) collagen mRNA in mice with bleomycin-induced pulmonary fibrosis.
Lucey EC; Ngo HQ; Agarwal A; Smith BD; Snider GL; Goldstein RH
Lab Invest; 1996 Jan; 74(1):12-20. PubMed ID: 8569173
[TBL] [Abstract][Full Text] [Related]
20. An endostatin-derived peptide orally exerts anti-fibrotic activity in a murine pulmonary fibrosis model.
Nishimoto T; Mlakar L; Takihara T; Feghali-Bostwick C
Int Immunopharmacol; 2015 Oct; 28(2):1102-5. PubMed ID: 26315492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
